Product analysis: the device remains implanted, therefore no product analysis can be performed.
Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.
If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that four years, nine months and six days following the implant of this transcatheter pulmonary bioprosthetic valve without pre-stenting, patient outgrowth of the device revealed stenosis.
Intervention was required for the stenosis.
A dilation was occurred with a high-pressure balloon.
The dilation revealed a stent fracture of the valve and required the implant of a stent and a second transcatheter pulmonary bioprosthetic valve.
No additional adverse patient effects were reported.
|